Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Watts

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Nature Medicine|July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue samplingKirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Nature Genetics|June 4, 2021
A map of transcriptional heterogeneity and regulatory variation in human microgliaAdam M H Young, Natsuhiko Kumasaka, Fiona Calvert, et al.
Lancet (London, England)|January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
Neuro-Oncology|October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysisYouri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Scientific Reports|September 12, 2018
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signaturesGrace Collord, Patrick Tarpey, Natalja Kurbatova, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Nature Medicine|December 12, 2018
The molecular landscape of glioma in patients with Neurofibromatosis 1Fulvio D'Angelo, Michele Ceccarelli, Tala, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Nature Medicine|July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue samplingKirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Nature Genetics|June 4, 2021
A map of transcriptional heterogeneity and regulatory variation in human microgliaAdam M H Young, Natsuhiko Kumasaka, Fiona Calvert, et al.
Lancet (London, England)|January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
Neuro-Oncology|October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysisYouri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Scientific Reports|September 12, 2018
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signaturesGrace Collord, Patrick Tarpey, Natalja Kurbatova, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Nature Medicine|December 12, 2018
The molecular landscape of glioma in patients with Neurofibromatosis 1Fulvio D'Angelo, Michele Ceccarelli, Tala, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Pageof 19